ARCHIVES

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

This article is from The Cancer Letter archive.

Vol. 26 No. 08 | February 25, 2000

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

May 11, 2007

Henschke and Supporters Call For Urgent Action Based On Results Of NLST

May 13, 2011

Bristol-Myers, USDA Agreement n Yew Harvest Is Near; Agencies Plan Public Briefings On Taxol

June 14, 1991

R. Lee Clark Clinic Dedication To Honor M.D. Anderson’s “Architect”

November 13, 1987

Coalitions Diverge On NIH Role, Agree On Need For More Basic Research

February 19, 1993

Data On CT Screening For Lung Cancer Raises Questions About DOD Program

April 23, 2010